Comprehensive Medication Monitoring on Heart Failure Patient Outcomes

Withdrawn before enrolling · Not applicable

Conditions studied: Heart Failure，Congestive

In brief

The purpose of this study is to evaluate the clinical utility of comprehensive medication monitoring using the Patient Medication Profile to improve heart failure patient medication therapy and associated outcomes relative to usual care in a hospital setting.

Key facts

Study ID

NCT03519477

Run by

Precera Bioscience, Inc.

People needed

0

Starts

2018-09-01

Expected to finish

2019-01-21

Last updated by the study team

2019-01-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have a regularly scheduled visit to a University of Pittsburgh Medical Center (UPMC) cardiology clinic in Oakland
• Patients must have Heart Failure with Reduced Ejection Fraction (≤40%)
• Patients have admitted to UPMC hospital facility between one and five times in past 12 months
• Patients must be able to provide informed consent for present study
• Patient age > 18 years

You may not qualify if…

• Enrolled in Hospice
• Patient on home inotrope (Dobutamine or milrinone)
• World Health Organization (WHO) Group 1 or Group 5 pulmonary hypertension
• Patient with current ventricular assist device (VAD)
• Not able to communicate in English

Where it is running

• UPMC Heart and Vascular Institute — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.